Black Friday Sale: 20% off everything. Ends Tuesday 1 December, 11:59 pm AEDT.
For laboratory and research use only. Not for human consumption.  Sold exclusively to qualified researchers and licensed laboratories.

CATALOGUE  /  GHK-CU

GHK-CU 50MG

GHK-Cu, lyophilised powder in a sealed vial

GHK-Cu

Research peptide · Lyophilised powder in a sealed vial · for laboratory and research use only

GHK-Cu 50mg Quantity per vial: 50mg
$79.99$63.99
Secure card payments
Not a drug, food or cosmetic. For laboratory and research use only. Not for human consumption. This product has not been evaluated or approved by the US Food and Drug Administration (FDA) or the Australian Therapeutic Goods Administration (TGA), and it is not intended to diagnose, treat, cure or prevent any disease. Sold exclusively to qualified researchers and licensed laboratories.

Reagent specifications

CAS number89030-95-5 (prezatide copper); 49557-75-7 (GHK)
Molecular weight402.92 g/mol (1:1 complex as recorded); 340.38 g/mol (free GHK); PubChem reference values
StorageSealed, dry and dark at −20 °C or colder; −50 to −80 °C for long-term storage
Certificate of analysisAvailable on request · Request a COA

CAS number and molecular weight are reference values for the compound identity, from PubChem. PubChem holds records for both 1:1 and 2:1 peptide-to-copper forms.

Compound identity

Compound classCopper(II)–tripeptide complex
Sequence (one-letter)GHK (Gly-His-Lys), complexed with Cu(II)
Molecular formulaC14H23CuN6O4+ (1:1 complex as recorded by PubChem, prezatide copper); C14H24N6O4 (free GHK)
PubChem CID71587328 (prezatide copper); 73587 (GHK)
Other namesCopper tripeptide-1, prezatide copper, GHK copper
Supplied asLyophilised powder, sealed vial
Quantity per vial50 mg
Intended useLaboratory and research use only

About GHK-Cu

GHK-Cu is the copper(II) complex of GHK (glycyl-L-histidyl-L-lysine), a tripeptide first reported in human plasma in 1973 that binds copper(II) strongly.1 It is also known as copper tripeptide-1 and, as a nonproprietary name, prezatide copper.2

Titan Peptides supplies GHK-Cu as a lyophilised powder in a sealed 50 mg vial, for laboratory and research use only. It is a research chemical: not a drug, food or cosmetic, and not for human consumption.

Status in Australia

GHK-Cu is not named in the Poisons Standard June 2026 (F2026L00633). The instrument does contain a general Schedule 4 entry for "copper compounds for human use", with exceptions that include preparations containing 5% or less of copper compounds.3 The TGA's 13 April 2026 safety advisory names GHK-Cu as an example of an unapproved peptide product, not evaluated by the TGA for safety, quality or effectiveness, and states that a "research use only" disclaimer does not make supply lawful.4

The GHK-Cu sold here is a research chemical, not an approved therapeutic good. See research peptides and Australian law.

Laboratory handling & storage

Store the sealed vial dry, dark and frozen at −20 °C or colder, and let it reach room temperature in a desiccator before opening. The copper centre adds two bench considerations: the complex exists as several species depending on pH, so buffer choice can change what is actually in solution, and its blue colour can interfere with absorbance-based or colorimetric assays. PubChem holds records for both 1:1 and 2:1 peptide-to-copper forms, so confirm which form a document describes before comparing its formula or mass with a record. Keep solutions short-lived, in single-use frozen aliquots. See how to store peptides and reconstituting peptides with bacteriostatic or sterile water for the reasoning behind each step.

GHK-Cu quick answers

What form and quantity is GHK-Cu supplied in?

GHK-Cu is supplied as a lyophilised powder in a sealed vial containing 50 mg, for laboratory and research use only. Solutions of the complex are blue, the usual colour of copper(II) compounds of this type. Because PubChem records 1:1 and 2:1 peptide-to-copper forms with different formulas and masses, the stated form and any counter-ion matter when reading documentation.

What is the CAS number of GHK-Cu?

PubChem lists prezatide copper, the 1:1 copper complex also called copper tripeptide-1, under CAS 89030-95-5 and CID 71587328, with formula C14H23CuN6O4+ and molar mass 402.92 g/mol as recorded. Free GHK, the tripeptide without copper, has CAS 49557-75-7 and CID 73587, formula C14H24N6O4 and molar mass 340.38 g/mol.

Is GHK-Cu the same as AHK-Cu?

No. AHK-Cu is L-alanyl-L-histidyl-L-lysine bound to copper, a different complex with a different formula and mass. Check the sequence a document or study used rather than the label 'copper peptide'.

Is GHK-Cu legal in Australia?

GHK-Cu is not named in the June 2026 Poisons Standard, which does contain a general Schedule 4 entry for copper compounds for human use. The TGA lists GHK-Cu among its examples of unapproved peptide products and says a research-use-only label does not make supply lawful. The GHK-Cu sold here is a research chemical, not an approved therapeutic good.

From the research library

Compound Profiles

GHK-Cu Copper Peptide: Compound Profile and Chemistry

A chemical profile of GHK-Cu, the copper(II) complex of the tripeptide glycyl-L-histidyl-L-lysine: how the copper is bound, the 1:1 and 2:1 forms, the names in use, bench handling and regulation.

21 September 2026 · 3 min read

References

  1. PubChem. GHK (glycyl-L-histidyl-L-lysine), CID 73587. National Center for Biotechnology Information. Source
  2. PubChem. Prezatide copper, CID 71587328. National Center for Biotechnology Information. Source
  3. Therapeutic Goods (Poisons Standard—June 2026) Instrument 2026 (Standard for the Uniform Scheduling of Medicines and Poisons No. 48), F2026L00633. Commenced 1 June 2026. Federal Register of Legislation. Source
  4. Therapeutic Goods Administration. Understanding your responsibilities when importing, compounding and supplying unapproved peptide products (safety advisory). Published 13 April 2026. Source
Research use only. Not a drug, food or cosmetic. GHK-Cu is supplied strictly for laboratory and in-vitro research and is not for human consumption. It is not an approved therapeutic good in Australia, has not been evaluated or approved by the FDA or the TGA, and is not intended to diagnose, treat, cure or prevent any disease. Titan Peptides sells exclusively to qualified researchers and licensed laboratories.